ICLR Stock Analysis: Buy, Sell, or Hold?
ICLR - Icon Plc
$114.19
2.77 (2.49%)
▲
5d:
+10.78%
30d:
+3.62%
90d:
-37.33%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Smart Money Distribution
ICLR is up 11.4% this week, but smart money is buying puts. Top strike: $95 2026-05-15 with 355 OI. Put ratio: 70% View Scanner →
Strength: 7.7/10
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICLR shows positive signals but monitor for confirmation. Market pricing in 6.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ICLR shows positive signals but monitor for confirmation. Market pricing in 6.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$140.38
Based on 0.3% avg growth
INTRINSIC VALUE TODAY
$87.17
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $114.19, which is considered extended relative to its 30-day fair value range of $99.57 to $109.25. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.1) compared to its historical average (11.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ICLR is in a strong downtrend. The price is approaching resistance at $115.62. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ICLR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $134.69 (+18.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICLR is in a strong downtrend. The price is approaching resistance at $115.62. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ICLR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $134.69 (+18.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$99.57 -
$109.25
Company Quality Score
60/100
(HOLD)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 24th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($134.69)
Fair Price Analysis
30-Day Fair Range
$99.57 -
$109.25
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$10.33
(9.0%)
Support & Resistance Levels
Support Level
$97.11
Resistance Level
$115.63
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.13
Wall Street Target
$134.69
(+18.0%)
Revenue Growth (YoY)
0.6%
Earnings Growth (YoY)
-98.7%
Profit Margin
7.4%
Valuation Discount vs History
-6.4% cheaper
PE vs Historical
9.1 vs 11.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.4%
(market-implied from PE analysis)
1-Year Target
$106.88
(-6%)
2-Year Target
$100.04
(-12%)
3-Year Target
$93.64
(-18%)
3-Yr Target (if PE normalizes)
(PE: 9→11)
$113.89
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: -3.5%)
$231.49
(+103%)
Base:
(SPY PE: 9.1, Growth: -3.5%)
$102.71
(-10%)
Bear:
(PE: 7.8, Growth: -3.5%)
$87.30
(-24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 13.44 | Current EPS (TTM): $7.42
Bull Case
$187.19
(+87%)
Analyst growth 70.7%, PE expands to 14.8
Base Case
$170.17
(+70%)
Market implied 70.7%, PE stable at 13.4
Bear Case
$67.80
(-32%)
Severe decline -20.0%, PE contracts to 11.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.1 to 11.1
Stabilization Target:
$138.88
(+21.6%)
PE Expansion Potential:
+21.6%
Share & Embed Analysis
Last updated: April 02, 2026 5:47 PM ET
Data refreshes hourly during market hours. Next update: 6:47 PM
Data refreshes hourly during market hours. Next update: 6:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 67 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 62 BUY |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
